Carbamazepine dihydrate

An analog of L-carnitine that, in the range of 0.25-1 mM, inhibits the uptake of L-carnitine by cells.

An analog of L-carnitine that, in the range of 0.25-1 mM, inhibits the uptake of L-carnitine by cells.

InformationDibutyryl-cAMP (Bucladesine) Dibutyryl-cAMP (Bucladesine, dbcAMP) is a cell-permeable PKA activator by mimicing the action of endogenous cAMP. Dibutyryl-cAMP (Bucladesine) is also a phosphodiesterase (PDE) inhibitor.In vitroDibutyryl-cAMP

Enzymatic protein deglycosylation kit contains all the enzymes and reagents required for the complete removal of N -linked and simple O -linked carbohydrates from glycoproteins. This kit is employed to cleave the complex Core 2 O -linked

This Certified Spiking Solution &#174 is suitable for testing flubromazolam by HPLC, GC/MS or LC-MS/MS methods in forensic analysis, clinical toxicology, urine drug testing, and cannabis potency or impurity profiling testing applications.

L-(-)-Glucose is an enantiomer of the more common D-glucose. L-Glucose cannot be used by cells as an energy source because it cannot be phosphorylated by hexokinase.An enantiomer of the more common D-glucose.

Licarbazepine-d 4 is the deuterium labeled Licarbazepine ( HY-108506 ). Licarbazepine is a voltage-gated sodium channel blocker with anticonvulsant and mood-stabilizing effects.In VitroStable heavy isotopes of hydrogen, carbon, and other elements

The keto derivative of Carbamazepine. Only available as a mixture of deuterated material:d-1: 1%d-2: 9%d-3: 35%d-4: 55%.

Quetiapine是非典型的抗精神病化合物，可作用于精神分裂，狂躁和抑郁症。.

S-10-Monohydroxy-dihydro-carbamazepin is an optically active metabolite of carbamazepine.

An anti-epileptic drug that inhibits the synaptosomal uptake of GABA, increasing the activation of GABAA receptors inhibits CYP3A4, CYP1A2, and CYP2C19 inhibits LDH, blocking both lactate-to-pyruvate and pyruvate-to-lactate conversions by human

An anti-epileptic drug that inhibits the synaptosomal uptake of GABA, increasing the activation of GABAA receptors inhibits CYP3A4, CYP1A2, and CYP2C19 inhibits LDH, blocking both lactate-to-pyruvate and pyruvate-to-lactate conversions by human